Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Lampert Mark N
Relationship:   10% Owner
City:   San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   44    
Direct Shares   110,762,579    

Indirect Shares

   88,557,834      
Direct Value   $1,430,535,692    

Indirect Value

   $1,617,324,755      
Total Shares   199,320,413      
Total Value   $3,047,860,447      


Repligen Corp $536,602,749 Dynavax Technologies Corp $66,451,437 Adolor Corp $0 Arqule Inc $15,426,100 Astex Pharmaceuticals Inc $0 Infinity Pharmaceuticals Inc $1 XOMA Corporation $43,093,427 Alpine Immune Sciences Inc $13,105,606 Glycomimetics Inc $168,079 Xenon Pharmaceuticals Inc. $0 Concert Pharmaceuticals, Inc. $1,419,460 Syndax Pharmaceuticals Inc $1,849,577 Immune Design Corp. $0 Pieris Pharmaceuticals, Inc. $2,970,733 Calithera Biosciences, Inc. $9,609 Five Prime Therapeutics Inc $237,959,230 Cytokinetics Inc $28,767,452 Merus Nv $10,361,896 Ideaya Biosciences, Inc. $0 Kymera Therapeutics, Inc. $0 Eledon Pharmaceuticals Ord Shs $335,017 Olema Pharmaceuticals, Inc. $0 Cytomx Therapeutics, Inc. $0 Repare Therapeutics Inc. $0 Verastem, Inc. $232,626,568 ESSA Pharma Inc $0 Third Harmonic Bio, Inc. $2,871,577 Structure Therapeutics Inc. $185,330,567 Engene Holdings Inc. $31,611,162 Allakos Inc. $19,575,446 Repligen Corp $536,602,749 Dynavax Technologies Corp $66,451,437 Adolor Corp $0 Arqule Inc $15,426,100 Astex Pharmaceuticals Inc $0 Infinity Pharmaceuticals Inc $1 XOMA Corporation $43,093,427 Alpine Immune Sciences Inc $13,105,606 Glycomimetics Inc $168,079 Xenon Pharmaceuticals Inc. $0 Concert Pharmaceuticals, Inc. $1,419,460 Syndax Pharmaceuticals Inc $1,849,577 Immune Design Corp. $0 Pieris Pharmaceuticals, Inc. $2,970,733 Calithera Biosciences, Inc. $9,609 Five Prime Therapeutics Inc $237,959,230 Cytokinetics Inc $28,767,452 Merus Nv $10,361,896 Ideaya Biosciences, Inc. $0 Kymera Therapeutics, Inc. $0 Eledon Pharmaceuticals Ord Shs $335,017 Olema Pharmaceuticals, Inc. $0 Cytomx Therapeutics, Inc. $0 Repare Therapeutics Inc. $0 Verastem, Inc. $232,626,568 ESSA Pharma Inc $0 Third Harmonic Bio, Inc. $2,871,577 Structure Therapeutics Inc. $185,330,567 Engene Holdings Inc. $31,611,162 Allakos Inc. $19,575,446
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    50   
    13    

     Stock price went up :
    40   
    4    
     Stock price went down :
    10   
    9    
   
     Gain/Loss Ratio :
   4.0   
   4.0   
     Percentage Gain/Loss :
   103.0%
 -82.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Arena Pharmaceuticals Inc ARNA Director, 10% Owner 2003-10-17 0 2003-10-17 4,520,212    Premium*  
            Repligen Corp RGEN 10% Owner 2009-05-15 3,216,850 0    Premium*  
            Dynavax Technologies Corp DVAX Indirect Beneficial Ow... 2009-06-19 6,193,051 2009-06-19 18,579,153    Premium*  
            Adolor Corp ADLR 10% Owner 2009-09-22 4,123,551 2009-09-22 12,370,653    Premium*  
            Gyre Therapeutics GYRE 10% Owner 0 2012-11-08 1,052,258    Premium*  
            Arqule Inc ARQL 10% Owner 2018-05-30 771,305 2010-04-05 12,624,219    Premium*  
            Astex Pharmaceuticals Inc ASTX 10% Owner 2010-04-20 5,583,399 2010-04-20 16,750,197    Premium*  
            Capstone Therapeutics Corp CAPS See Explanation of Res... 2011-06-27 0 2017-07-14 890,487    Premium*  
            Ligand Pharmaceuticals Inc LGND See Explanation of Res... 0 2014-03-25 130,175    Premium*  
            Icagen Inc ICGN 10% Owner 2011-09-07 0 2011-09-07 625,400    Premium*  
            Palatin Technologies Inc PTN 10% Owner 0 2014-02-27 2,494,521    Premium*  
            Neurocrine Biosciences Inc NBIX 10% Owner 2011-10-10 0 2011-10-12 3,527,700    Premium*  
            Kent International Inc KNTH See Explanation of Res... 2011-12-23 0 2011-12-23 0    Premium*  
            Chemocentryx, Inc. CCXI 10% Owner 0 2012-11-06 3,750,277    Premium*  
            Rigel Pharmaceuticals Inc RIGL 10% Owner 0 2013-06-07 7,761,738    Premium*  
            Cascadian Therapeutics, Inc CASC 10% Owner 2013-06-05 0 2015-02-05 1,898,293    Premium*  
            Tobira Therapeutics Inc TBRA See Explanation of Res... 0 2014-03-21 1,121,221    Premium*  
            Cti Biopharma Corporation CTIC See Explanation of Res... 2023-06-26 0 2023-06-26 0    Premium*  
            Infinity Pharmaceuticals Inc INFI 10% Owner 2021-02-11 534,847 2016-12-01 0    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2023-01-06 1,693,924 2023-01-06 361,774    Premium*  
            Alpine Immune Sciences Inc ALPN 10% Owner 2017-06-20 201,811 2017-05-09 0    Premium*  
            Glycomimetics Inc GLYC 10% Owner 2020-11-04 630,453 0    Premium*  
            Xenon Pharmaceuticals Inc. XENE 10% Owner 2018-03-27 59,464 2017-06-06 0    Premium*  
            Concert Pharmaceuticals, Inc. CNCE 10% Owner 2019-06-10 169,589 2017-10-19 0    Premium*  
            Syndax Pharmaceuticals Inc SNDX 10% Owner 2018-06-18 85,038 2018-06-18 0    Premium*  
            Immune Design Corp. IMDZ 10% Owner 2018-12-04 370,391 2018-12-04 0    Premium*  
            Pieris Pharmaceuticals, Inc. PIRS 10% Owner 2023-05-11 20,333,557 2019-01-30 0    Premium*  
            Calithera Biosciences, Inc. CALA 10% Owner 2020-05-21 480,432 0    Premium*  
            Five Prime Therapeutics Inc FPRX 10% Owner 2021-03-04 6,262,085 0    Premium*  
            Cytokinetics Inc CYTK See Explanation of Res... 2020-12-09 463,244 2019-12-10 0    Premium*  
            Merus Nv MRUS 10% Owner 2021-10-08 232,747 0    Premium*  
            Ideaya Biosciences, Inc. IDYA See Explanation of Res... 2021-02-02 233,150 2020-06-19 0    Premium*  
            Kymera Therapeutics, Inc. KYMR See Remarks and Footno... 2023-11-03 294,632 2020-08-21 0    Premium*  
            Eledon Pharmaceuticals Ord Shs ELDN 10% Owner 2023-05-05 145,029 0    Premium*  
            Olema Pharmaceuticals, Inc. OLMA Director, 10% Owner 2023-09-12 524,151 2023-09-14 99,556    Premium*  
            Cytomx Therapeutics, Inc. CTMX 10% Owner 2020-12-18 5,468,599 0    Premium*  
            Rain Therapeutics Inc. RAIN See Remarks; Former 10... 2024-01-25 0 2021-04-23 0    Premium*  
            Repare Therapeutics Inc. RPTX 10% Owner 2023-11-16 548,938 0    Premium*  
            Verastem, Inc. VSTM 10% Owner 2022-01-25 19,630,934 0    Premium*  
            ESSA Pharma Inc EPIX 10% Owner 2022-07-11 8,561,841 0    Premium*  
            Third Harmonic Bio, Inc. THRD 10% Owner 2022-12-20 241,309 2022-12-20 0    Premium*  
            Structure Therapeutics Inc. GPCR 10% Owner 2023-05-10 5,173,941 0    Premium*  
            Engene Holdings Inc. ENGN 10% Owner 2023-10-31 2,221,445 0    Premium*  
            Allakos Inc. ALLK 10% Owner 2024-01-16 16,312,872 0    Premium*  
* Premium Members only  

Records found :    355         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 7 of 15
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
KYMR Kymera Therapeutics, Inc. See Remarks and Footnotes   –       •      –    2022-05-20 4 B $14.00 $141,394 D/D 10,100 216,772 2.39 -
XOMA XOMA Corporation 10% Owner   –       –       •   2020-03-25 4 B $17.20 $142,129 D/D 8,264 1,278,656 2.45 %
XOMA XOMA Corporation 10% Owner   –       –       •   2020-09-04 4 B $18.77 $145,228 D/D 7,737 1,728,443 2.45 %
ALPN Alpine Immune Sciences In... 10% Owner   –       –       •   2017-05-10 4 B $2.35 $145,433 D/D 62,000 177,753 2.45 -
CASC Cascadian Therapeutics, I... See Explanation of Responses   –       –       •   2013-06-06 4 B $1.78 $147,663 I/I 82,915 2,335,991 1.5 -
FPRX Five Prime Therapeutics I... 10% Owner   –       –       •   2020-11-06 4 B $4.98 $149,520 D/D 30,000 583,912 2.45 %
XOMA XOMA Corporation 10% Owner   –       –       •   2018-11-29 4 B $14.93 $149,543 D/D 10,016 586,255 2.45 -
XOMA XOMA Corporation 10% Owner   –       –       •   2018-11-16 4 B $13.82 $149,986 D/D 10,849 484,302 2.45 -
XOMA XOMA Corporation 10% Owner   –       –       •   2019-05-10 4 B $14.57 $150,037 D/D 10,300 728,841 2.45 -
RAIN Rain Therapeutics Inc. 10% Owner   –       –       •   2021-09-21 4 B $13.94 $153,829 D/D 11,033 170,582 2.45 -
XOMA XOMA Corporation 10% Owner   –       –       •   2020-03-16 4 B $15.73 $159,916 D/D 10,164 1,257,840 2.45 %
XOMA XOMA Corporation 10% Owner   –       –       •   2018-12-06 4 B $14.80 $161,698 D/D 10,927 606,982 2.45 -
LGND Ligand Pharmaceuticals In... See Explanation of Responses   –       –       •   2011-10-20 4 B $13.93 $165,809 I/I 11,900 1,735,000 1.5 -
ADLR Adolor Corp Direct Beneficial Owner   –       –       •   2009-09-14 4 S $1.79 $169,851 D/D (95,000) 5,372,551 0 -
XOMA XOMA Corporation 10% Owner   –       –       •   2018-11-27 4 B $15.24 $173,680 D/D 11,396 567,951 2.45 -
NBIX Neurocrine Biosciences In... See Explanation of Responses   –       –       •   2011-10-12 4 B $5.96 $175,673 I/I 29,500 3,527,700 1.5 -
INFI Infinity Pharmaceuticals ... Director   –       •       •   2016-12-01 4 B $1.18 $176,365 D/D 148,894 547,554 3.92 -
ADLR Adolor Corp Direct Beneficial Owner   –       –       •   2009-09-17 4 S $1.70 $183,600 D/D (108,000) 4,771,551 0 -
LGND Ligand Pharmaceuticals In... See Explanation of Responses   –       –       •   2011-10-04 4 B $12.78 $183,961 I/I 14,400 362,080 1.5 -
CAPS Capstone Therapeutics Cor... 10% Owner   –       –       •   2014-07-01 4 D $0.30 $184,969 I/I (616,563) 3,993,637 0 -
LGND Ligand Pharmaceuticals In... See Explanation of Responses   –       –       •   2012-10-26 4 B $15.26 $190,926 I/I 12,515 737,551 1.5 -
LGND Ligand Pharmaceuticals In... See Explanation of Responses   –       –       •   2011-08-18 4 B $11.91 $197,371 I/I 16,571 1,652,562 1.5 -
GYRE Gyre Therapeutics See Explanation of Responses   –       –       •   2012-11-08 4 B $4.01 $197,651 I/I 49,329 1,052,258 1.5 -
XOMA XOMA Corporation 10% Owner   –       –       •   2019-05-14 4 B $14.74 $203,664 D/D 13,816 746,454 2.45 -
XOMA XOMA Corporation 10% Owner   –       –       •   2020-08-21 4 B $19.32 $208,770 D/D 10,805 1,701,734 2.45 %
  355  Records found
  1   2   3   4   5   6   7  8   9   10   11   12   13   14   15      
  Page 7 of 15  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us